Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies

Koji Kawamura, Misato Kikuchi, Kiriko Terasako, Hidenori Wada, Ryoko Yamasaki, Yuko Ishihara, Kana Sakamoto, Masahiro Ashizawa, Miki Sato, Tomohito Machishima, Shun ichi Kimura, Hideki Nakasone, Shinya Okuda, Rie Yamazaki, Junya Kanda, Shinichi Kako, Yukie Tanaka, Aki Tanihara, Junji Nishida, Yoshinobu Kanda

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Peripheral blood stem cell (PBSC) collection using granulocyte colony-stimulating factor (G-CSF) alone is superior to the combination of chemotherapy and G-CSF in terms of low morbidity, short duration of mobilization and low cost. We retrospectively compared the results of PBSC collection using G-CSF alone in 11 patients with malignant lymphoma (ML), 23 patients with plasma cell neoplasms (PCN) and 48 healthy donors. The geometric mean number of CD34+ cells/kg obtained on the first day of collection was 0.99×106/kg in ML patients, 2.26×106/kg in PCN patients, and 3.36×106/kg in healthy donors. The probability of collecting at least 1×106/kg CD34+ cells/kg during a single course of apheresis was 90.9% in ML patients, 95.7% in PCN patients, and 100% in healthy donors. In a multiple regression analysis of the CD34+ cell yields on the first day of apheresis, we identified disease, the baseline white blood cell count (WBC), platelet count, and lactate dehydrogenase as independent significant variables. Particularly, disease was strongly associated with the CD34+ cell yield, probably due to the difference in the number of previous chemotherapy cycles. In conclusion, the minimal dose of CD34+ cells for autologous transplantation was collected in almost all patients with hematological malignancies. However, patients who have received repeated cycles of chemotherapy, such as patients with ML, and those who have low WBC counts and/or platelet counts may be at higher risk for poor mobilization.

Original languageEnglish
Pages (from-to)334-340
Number of pages7
JournalTransfusion and Apheresis Science
Volume49
Issue number2
DOIs
Publication statusPublished - 2013 Oct 1
Externally publishedYes

Fingerprint

Hematopoietic Stem Cell Mobilization
Granulocyte Colony-Stimulating Factor
Hematologic Neoplasms
Tissue Donors
Plasma Cell Neoplasms
Lymphoma
Blood Component Removal
Platelet Count
Leukocyte Count
Peripheral Blood Stem Cells
Drug Therapy
Autologous Transplantation
Cell Transplantation
Combination Drug Therapy
L-Lactate Dehydrogenase
Cell Count
Regression Analysis
Morbidity
Costs and Cost Analysis

Keywords

  • CD34 cells
  • Granulocyte colony-stimulating factor
  • Malignant lymphoma
  • Mobilization
  • Peripheral blood stem cell

ASJC Scopus subject areas

  • Hematology

Cite this

Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies. / Kawamura, Koji; Kikuchi, Misato; Terasako, Kiriko; Wada, Hidenori; Yamasaki, Ryoko; Ishihara, Yuko; Sakamoto, Kana; Ashizawa, Masahiro; Sato, Miki; Machishima, Tomohito; Kimura, Shun ichi; Nakasone, Hideki; Okuda, Shinya; Yamazaki, Rie; Kanda, Junya; Kako, Shinichi; Tanaka, Yukie; Tanihara, Aki; Nishida, Junji; Kanda, Yoshinobu.

In: Transfusion and Apheresis Science, Vol. 49, No. 2, 01.10.2013, p. 334-340.

Research output: Contribution to journalArticle

Kawamura, K, Kikuchi, M, Terasako, K, Wada, H, Yamasaki, R, Ishihara, Y, Sakamoto, K, Ashizawa, M, Sato, M, Machishima, T, Kimura, SI, Nakasone, H, Okuda, S, Yamazaki, R, Kanda, J, Kako, S, Tanaka, Y, Tanihara, A, Nishida, J & Kanda, Y 2013, 'Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies', Transfusion and Apheresis Science, vol. 49, no. 2, pp. 334-340. https://doi.org/10.1016/j.transci.2013.06.005
Kawamura, Koji ; Kikuchi, Misato ; Terasako, Kiriko ; Wada, Hidenori ; Yamasaki, Ryoko ; Ishihara, Yuko ; Sakamoto, Kana ; Ashizawa, Masahiro ; Sato, Miki ; Machishima, Tomohito ; Kimura, Shun ichi ; Nakasone, Hideki ; Okuda, Shinya ; Yamazaki, Rie ; Kanda, Junya ; Kako, Shinichi ; Tanaka, Yukie ; Tanihara, Aki ; Nishida, Junji ; Kanda, Yoshinobu. / Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies. In: Transfusion and Apheresis Science. 2013 ; Vol. 49, No. 2. pp. 334-340.
@article{78752b4e34aa42558cab23ee21b1e8a5,
title = "Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies",
abstract = "Peripheral blood stem cell (PBSC) collection using granulocyte colony-stimulating factor (G-CSF) alone is superior to the combination of chemotherapy and G-CSF in terms of low morbidity, short duration of mobilization and low cost. We retrospectively compared the results of PBSC collection using G-CSF alone in 11 patients with malignant lymphoma (ML), 23 patients with plasma cell neoplasms (PCN) and 48 healthy donors. The geometric mean number of CD34+ cells/kg obtained on the first day of collection was 0.99×106/kg in ML patients, 2.26×106/kg in PCN patients, and 3.36×106/kg in healthy donors. The probability of collecting at least 1×106/kg CD34+ cells/kg during a single course of apheresis was 90.9{\%} in ML patients, 95.7{\%} in PCN patients, and 100{\%} in healthy donors. In a multiple regression analysis of the CD34+ cell yields on the first day of apheresis, we identified disease, the baseline white blood cell count (WBC), platelet count, and lactate dehydrogenase as independent significant variables. Particularly, disease was strongly associated with the CD34+ cell yield, probably due to the difference in the number of previous chemotherapy cycles. In conclusion, the minimal dose of CD34+ cells for autologous transplantation was collected in almost all patients with hematological malignancies. However, patients who have received repeated cycles of chemotherapy, such as patients with ML, and those who have low WBC counts and/or platelet counts may be at higher risk for poor mobilization.",
keywords = "CD34 cells, Granulocyte colony-stimulating factor, Malignant lymphoma, Mobilization, Peripheral blood stem cell",
author = "Koji Kawamura and Misato Kikuchi and Kiriko Terasako and Hidenori Wada and Ryoko Yamasaki and Yuko Ishihara and Kana Sakamoto and Masahiro Ashizawa and Miki Sato and Tomohito Machishima and Kimura, {Shun ichi} and Hideki Nakasone and Shinya Okuda and Rie Yamazaki and Junya Kanda and Shinichi Kako and Yukie Tanaka and Aki Tanihara and Junji Nishida and Yoshinobu Kanda",
year = "2013",
month = "10",
day = "1",
doi = "10.1016/j.transci.2013.06.005",
language = "English",
volume = "49",
pages = "334--340",
journal = "Transfusion and Apheresis Science",
issn = "1473-0502",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies

AU - Kawamura, Koji

AU - Kikuchi, Misato

AU - Terasako, Kiriko

AU - Wada, Hidenori

AU - Yamasaki, Ryoko

AU - Ishihara, Yuko

AU - Sakamoto, Kana

AU - Ashizawa, Masahiro

AU - Sato, Miki

AU - Machishima, Tomohito

AU - Kimura, Shun ichi

AU - Nakasone, Hideki

AU - Okuda, Shinya

AU - Yamazaki, Rie

AU - Kanda, Junya

AU - Kako, Shinichi

AU - Tanaka, Yukie

AU - Tanihara, Aki

AU - Nishida, Junji

AU - Kanda, Yoshinobu

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Peripheral blood stem cell (PBSC) collection using granulocyte colony-stimulating factor (G-CSF) alone is superior to the combination of chemotherapy and G-CSF in terms of low morbidity, short duration of mobilization and low cost. We retrospectively compared the results of PBSC collection using G-CSF alone in 11 patients with malignant lymphoma (ML), 23 patients with plasma cell neoplasms (PCN) and 48 healthy donors. The geometric mean number of CD34+ cells/kg obtained on the first day of collection was 0.99×106/kg in ML patients, 2.26×106/kg in PCN patients, and 3.36×106/kg in healthy donors. The probability of collecting at least 1×106/kg CD34+ cells/kg during a single course of apheresis was 90.9% in ML patients, 95.7% in PCN patients, and 100% in healthy donors. In a multiple regression analysis of the CD34+ cell yields on the first day of apheresis, we identified disease, the baseline white blood cell count (WBC), platelet count, and lactate dehydrogenase as independent significant variables. Particularly, disease was strongly associated with the CD34+ cell yield, probably due to the difference in the number of previous chemotherapy cycles. In conclusion, the minimal dose of CD34+ cells for autologous transplantation was collected in almost all patients with hematological malignancies. However, patients who have received repeated cycles of chemotherapy, such as patients with ML, and those who have low WBC counts and/or platelet counts may be at higher risk for poor mobilization.

AB - Peripheral blood stem cell (PBSC) collection using granulocyte colony-stimulating factor (G-CSF) alone is superior to the combination of chemotherapy and G-CSF in terms of low morbidity, short duration of mobilization and low cost. We retrospectively compared the results of PBSC collection using G-CSF alone in 11 patients with malignant lymphoma (ML), 23 patients with plasma cell neoplasms (PCN) and 48 healthy donors. The geometric mean number of CD34+ cells/kg obtained on the first day of collection was 0.99×106/kg in ML patients, 2.26×106/kg in PCN patients, and 3.36×106/kg in healthy donors. The probability of collecting at least 1×106/kg CD34+ cells/kg during a single course of apheresis was 90.9% in ML patients, 95.7% in PCN patients, and 100% in healthy donors. In a multiple regression analysis of the CD34+ cell yields on the first day of apheresis, we identified disease, the baseline white blood cell count (WBC), platelet count, and lactate dehydrogenase as independent significant variables. Particularly, disease was strongly associated with the CD34+ cell yield, probably due to the difference in the number of previous chemotherapy cycles. In conclusion, the minimal dose of CD34+ cells for autologous transplantation was collected in almost all patients with hematological malignancies. However, patients who have received repeated cycles of chemotherapy, such as patients with ML, and those who have low WBC counts and/or platelet counts may be at higher risk for poor mobilization.

KW - CD34 cells

KW - Granulocyte colony-stimulating factor

KW - Malignant lymphoma

KW - Mobilization

KW - Peripheral blood stem cell

UR - http://www.scopus.com/inward/record.url?scp=84886641408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886641408&partnerID=8YFLogxK

U2 - 10.1016/j.transci.2013.06.005

DO - 10.1016/j.transci.2013.06.005

M3 - Article

C2 - 23810219

AN - SCOPUS:84886641408

VL - 49

SP - 334

EP - 340

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

SN - 1473-0502

IS - 2

ER -